Anti-reflux surgery in the laparoscopic era

Area of Science:

• Gastroenterology
• Surgical Innovation
• Patient Management

Background:

• Laparoscopic anti-reflux surgery is gaining traction for gastro-oesophageal reflux disease (GORD).
• Modern acid-suppressive drugs manage chronic GORD but have limitations like symptom relapse and long-term safety concerns.
• Specific patient groups, including 'volume refluxers,' those with strictures, Barrett's oesophagus, or respiratory complications, are candidates for surgical intervention.

Purpose of the Study:

• To identify patient subgroups suitable for laparoscopic anti-reflux surgery.
• To emphasize the importance of appropriate surgical technique (fundoplication) and patient selection.
• To discuss the role of surgery in managing chronic GORD, considering its cost-effectiveness and impact on quality of life.

Main Methods:

• Review of patient groups indicated for anti-reflux surgery.
• Discussion of surgical techniques, including fundoplication and crural repair.
• Consideration of pre-operative patient factors and post-operative assessment.

Main Results:

• Laparoscopic surgery has low morbidity in experienced hands, potentially shifting treatment paradigms.
• Adequate crural repair is vital to prevent post-operative complications like herniation.
• Partial fundoplication shows promise in reducing dysphagia and gas bloat.

Conclusions:

• Careful patient selection is paramount for successful laparoscopic anti-reflux surgery.
• Surgical outcomes should be assessed comprehensively, including quality of life.
• Cost-effectiveness analyses support surgical intervention for chronic GORD management.